By using Thy-1 APP mice, an AD model that deposits plaques at 6 months of age, Hauptmann et al. (2009) showed mitochondrial dysfunction associated with higher levels of ROS, including mitochondrial membrane potential decrease and reduced ATP levels as soon as 3 months of age, when extracellular deposits are not present. This evidence concerns the gene APP and Alzheimer disease.